Range Cancer Therapeutics ETF (CNCR)

12.09 +0.07 (+0.58%) USD  |  NASDAQ  |  Dec 20, 16:00
12.15 +0.06 (+0.50%) After-Hours: 20:00
More

CNCR Monthly Value at Risk (VaR) 5% (Since Inception)

Monthly Value at Risk (VaR) 5% (Since Inception) Chart

View Monthly Value at Risk (VaR) 5% (Since Inception) for CNCR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Monthly Value at Risk (VaR) 5% (Since Inception) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Monthly Value at Risk (VaR) 5% (Since Inception) Range, Past 5 Years

View Monthly Value at Risk (VaR) 5% (Since Inception) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Monthly Value at Risk (VaR) 5% (Since Inception) Benchmarks

View Monthly Value at Risk (VaR) 5% (Since Inception) Benchmarks
Start Trial
SPDR S&P Pharmaceuticals ETF Upgrade
SPDR S&P Health Care Services ETF Upgrade
Virtus LifeSci Biotech Products ETF Upgrade
First Trust Nasdaq Pharmaceuticals ETF Upgrade
Simplify Propel Opportunities ETF Upgrade

Monthly Value at Risk (VaR) 5% (Since Inception) Related Metrics

Alpha (Since Inception) Upgrade
Beta (Since Inception) Upgrade
Alpha (vs YCharts Benchmark) (Since Inception) Upgrade
Beta (vs YCharts Benchmark) (Since Inception) Upgrade
Annualized Standard Deviation of Monthly Returns (Since Inception) Upgrade
Historical Sharpe Ratio (Since Inception) Upgrade
Historical Sortino (Since Inception) Upgrade
Max Drawdown (Since Inception) Upgrade